Genetic polymorphisms of Chinese patients with ischemic stroke and concurrent stenoses of extracranial and intracranial vessels.
The etiology of concurrent stenoses of extracranial and intracranial vessels in patients with ischemic stroke is poorly understood, but hereditary factors are believed to be important. We aimed to determine whether genetic polymorphisms affecting homocysteine and lipid metabolism are associated with concurrent stenoses. The genotypes of 191 Han Chinese patients with acute ischemic stroke, of whom 47 (25%) had concurrent stenoses, and 167 healthy control patients in Hong Kong were examined for the following polymorphisms: paraoxonase 1 (PON1) Q192R, methylenetetrahydrofolate reductase (MTHFR) A222V, glutamate-cysteine ligase catalytic-subunit (GCLC)-129C>T, and oxidized low-density lipoprotein receptor (OLR) 3' untranslated region C>T (rs1050283). The genotype distributions of PON1 Q192R and MTHFR A222V, which affect lipid and homocysteine metabolism, differed significantly between patients with stroke and healthy controls. The presence of at least one R allele in PON1 Q192R and a TT allele in OLR rs1050283 were associated with concurrent stenoses. We also identified a possible association between the presence of at least one V allele in MTHFR A222V and concurrent stenoses. This study shows that genetic polymorphisms affecting homocysteine and lipid metabolism are possible risk factors for stroke and concurrent stenoses.
Man
B L
BL
Department of Medicine and Geriatrics, Division of Neurology, Tuen Mun Hospital, 23 Tsing Chung Koon Road, Tuen Mun, New Territories, Hong Kong, China. anbikling@gmail.com
Baum
L
L
Fu
Y P
YP
Chan
Y Y
YY
Lam
W
W
Hui
C F
CF
Leung
W H
WH
Wong
K S
KS
D000368:Aged; D000369:Aged, 80 and over; D043303:Aryldialkylphosphatase / Q000235:genetics*; D044466:Asian People / Q000235:genetics; D003251:Constriction, Pathologic / Q000150:complications / Q000235:genetics*; D005260:Female; D005820:Genetic Testing; D005721:Glutamate-Cysteine Ligase / Q000235:genetics*; D006710:Homocysteine / Q000235:genetics; D006801:Humans; D050356:Lipid Metabolism / Q000235:genetics; D008077:Lipoproteins, LDL / Q000235:genetics*; D018810:Magnetic Resonance Angiography / Q000379:methods; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000235:genetics*; D020521:Stroke / Q000150:complications / Q000235:genetics*; D018616:Ultrasonography, Doppler, Duplex / Q000379:methods; D014633:Valine / Q000235:genetics
D008077:Lipoproteins, LDL; D006710:Homocysteine; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D043303:Aryldialkylphosphatase; C468406:PON1 protein, human; D005721:Glutamate-Cysteine Ligase; D014633:Valine